Dec 6 (Reuters) – U.S. President-elect Donald Trump’s plan
to incentivize U.S. companies to repatriate their swelling
overseas cash piles could spur a new wave of dealmaking in a
pharmaceutical…
The post DEALTALK-Trump’s corporate tax holiday could spur pharma M&A appeared first on NASDAQ.